Cargando…
Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms
Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639688/ https://www.ncbi.nlm.nih.gov/pubmed/23878753 http://dx.doi.org/10.1155/2013/485025 |
_version_ | 1782475980247400448 |
---|---|
author | Zamarrón, Carlos Abdulkader, Ihab Areses, María C. García-Paz, Vanesa León, Luís Cameselle-Teijeiro, José |
author_facet | Zamarrón, Carlos Abdulkader, Ihab Areses, María C. García-Paz, Vanesa León, Luís Cameselle-Teijeiro, José |
author_sort | Zamarrón, Carlos |
collection | PubMed |
description | Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography revealed elevated values in the thyroid gland, while the mediastinum was normal. An endoscopic ultrasonography-guided fine-needle aspiration biopsy of the mediastinal mass was consistent with CCRCC, and this was confirmed after resection. The thyroidectomy specimen also revealed lymphocytic thyroiditis, nodular hyperplasia, one follicular adenoma, two papillary microcarcinomas, and six foci of metastatic CCRCC involving both thyroid lobes. Curiously two of the six metastatic foci were located inside two adenomatoid nodules (tumor-in-tumor). The metastatic cells were positive for cytokeratins, CD10, epidermal growth factor receptor, and vascular endothelial growth factor receptor 2. No BRAF gene mutations were found in any of the primary and metastatic lesions. The patient was treated with sunitinib and finally died due to CCRCC distant metastases 6 years after the thyroidectomy. In CCRCC patients, a particularly prolonged survival rate may be achieved with the appropriate therapy, in contrast to the ominous prognosis typically found in patients with thyroid metastases from other origins. |
format | Online Article Text |
id | pubmed-3639688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-36396882013-07-22 Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms Zamarrón, Carlos Abdulkader, Ihab Areses, María C. García-Paz, Vanesa León, Luís Cameselle-Teijeiro, José Case Rep Oncol Med Case Report Clear cell renal cell carcinoma (CCRCC) is the most common origin for metastasis in the thyroid. A 51-year-old woman was referred to our hospital for a subcarinal lesion. Ten years before, the patient had undergone a nephrectomy for CCRCC. Whole-body fluorodeoxyglucose positron emission tomography revealed elevated values in the thyroid gland, while the mediastinum was normal. An endoscopic ultrasonography-guided fine-needle aspiration biopsy of the mediastinal mass was consistent with CCRCC, and this was confirmed after resection. The thyroidectomy specimen also revealed lymphocytic thyroiditis, nodular hyperplasia, one follicular adenoma, two papillary microcarcinomas, and six foci of metastatic CCRCC involving both thyroid lobes. Curiously two of the six metastatic foci were located inside two adenomatoid nodules (tumor-in-tumor). The metastatic cells were positive for cytokeratins, CD10, epidermal growth factor receptor, and vascular endothelial growth factor receptor 2. No BRAF gene mutations were found in any of the primary and metastatic lesions. The patient was treated with sunitinib and finally died due to CCRCC distant metastases 6 years after the thyroidectomy. In CCRCC patients, a particularly prolonged survival rate may be achieved with the appropriate therapy, in contrast to the ominous prognosis typically found in patients with thyroid metastases from other origins. Hindawi Publishing Corporation 2013 2013-04-11 /pmc/articles/PMC3639688/ /pubmed/23878753 http://dx.doi.org/10.1155/2013/485025 Text en Copyright © 2013 Carlos Zamarrón et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Zamarrón, Carlos Abdulkader, Ihab Areses, María C. García-Paz, Vanesa León, Luís Cameselle-Teijeiro, José Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title | Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title_full | Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title_fullStr | Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title_full_unstemmed | Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title_short | Metastases of Renal Cell Carcinoma to the Thyroid Gland with Synchronous Benign and Malignant Follicular Cell-Derived Neoplasms |
title_sort | metastases of renal cell carcinoma to the thyroid gland with synchronous benign and malignant follicular cell-derived neoplasms |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639688/ https://www.ncbi.nlm.nih.gov/pubmed/23878753 http://dx.doi.org/10.1155/2013/485025 |
work_keys_str_mv | AT zamarroncarlos metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms AT abdulkaderihab metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms AT aresesmariac metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms AT garciapazvanesa metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms AT leonluis metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms AT cameselleteijeirojose metastasesofrenalcellcarcinomatothethyroidglandwithsynchronousbenignandmalignantfollicularcellderivedneoplasms |